TCIM
RMD icon

TIAA CREF Investment Management’s ResMed RMD Stock Holding History

TIAA CREF Investment Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$34.1M Buy
328,356
+45,572
+16% +$4.7M 0.02% 503
2018
Q4 		$32.2M Sell
282,784
-201,848
-42% -$21.6M 0.03% 499
2018
Q3 		$55.9M Buy
484,632
+112,407
+30% +$12.3M 0.04% 410
2018
Q2 		$38.6M Buy
372,225
+13,365
+4% +$1.35M 0.03% 511
2018
Q1 		$35.3M Buy
358,860
+41,800
+13% +$3.95M 0.02% 546
2017
Q4 		$26.9M Sell
317,060
-26,633
-8% -$2.2M 0.02% 653
2017
Q3 		$26.5M Sell
343,693
-60,760
-15% -$4.65M 0.02% 641
2017
Q2 		$31.5M Sell
404,453
-186,501
-32% -$13.3M 0.02% 580
2017
Q1 		$42.5M Buy
590,954
+23,836
+4% +$1.65M 0.03% 489
2016
Q4 		$35.2M Buy
567,118
+5,345
+1% +$327K 0.03% 540
2016
Q3 		$36.4K Sell
561,773
-38,745
-6% -$2.58M 0.02% 543
2016
Q2 		$38M Sell
600,518
-50,424
-8% -$2.97M 0.03% 513
2016
Q1 		$37.6M Buy
650,942
+165,025
+34% +$9.34M 0.03% 521
2015
Q4 		$26.1M Buy
485,917
+47,437
+11% +$2.67M 0.02% 672
2015
Q3 		$22.3M Buy
438,480
+22,726
+5% +$1.22M 0.02% 706
2015
Q2 		$23.4M Sell
415,754
-56,786
-12% -$3.58M 0.02% 731
2015
Q1 		$33.9M Buy
472,540
+8,382
+2% +$544K 0.02% 601
2014
Q4 		$26M Buy
464,158
+7,476
+2% +$390K 0.02% 670
2014
Q3 		$22.5M Sell
456,682
-27,561
-6% -$1.4M 0.02% 728
2014
Q2 		$24.5M Sell
484,243
-12,230
-2% -$606K 0.02% 716
2014
Q1 		$22.2M Sell
496,473
-12,603
-2% -$566K 0.02% 752
2013
Q4 		$24M Sell
509,076
-222,345
-30% -$11.3M 0.02% 717
2013
Q3 		$38.6M Sell
731,421
-149,790
-17% -$7.27M 0.03% 538
2013
Q2 		$39.8M Buy
+881,211
New +$41.8M 0.03% 516

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

TIAA CREF Investment Management's RMD Position: Q1 2019 in Review

TIAA CREF Investment Management increased its ResMed (RMD) stake by 16% in Q1 2019, buying an estimated $4.7M and bringing the position to 328,356 shares worth $34.1M. The position accounts for 0.02% of the portfolio, ranked #503.

TIAA CREF Investment Management first reported a position in RMD in Q2 2013 and has held it in 24 quarters since. The position peaked at $55.9M in Q3 2018. 477 funds tracked by Wall St. Rank hold RMD as of Q1 2019.

  • TIAA CREF Investment Management held 328,356 shares of ResMed worth $34.1M as of Q1 2019.
  • TIAA CREF Investment Management bought 45,572 ResMed shares in Q1 2019, an estimated $4.7M.
  • ResMed made up 0.02% of TIAA CREF Investment Management's portfolio in Q1 2019, its #503 holding.
  • TIAA CREF Investment Management first reported a position in ResMed in Q2 2013 and has held it in 24 quarters since.
  • TIAA CREF Investment Management's ResMed position peaked at $55.9M in Q3 2018.
  • 477 funds tracked by Wall St. Rank held ResMed as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.